Close Menu

Cardiovascular Disease

News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.

A two-stage, case-control genetic association study has implicated rare variants in the PTGIS gene in idiopathic pulmonary arterial hypertension susceptibility.

Although polygenic risk scores for coronary artery disease can slightly improve standard risk assessment tools, the predicted clinical impact remains small.

Understanding the genetic causes of hypercholesterolemia could provide prognostic information to help treat patients, the researchers said.

The Ottawa-based molecular diagnostics maker also plans to enter applied markets in the near term, and ultimately point-of-care infectious disease testing.

Nine of the genes analyzed had limited or disputed evidence linking them to long QT syndrome, suggesting they should not be included in genetic testing panels.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.